Company / AR per Share
Regeneron Pharmaceuticals AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$50.49
FY2025
5-year range
$46.30 / $54.73
FY2021-FY2025
Trend
-7.7%
vs FY2024
Sector context
#3 of 113
Health Care
What the data says
Among 113 Health Care companies, Regeneron Pharmaceuticals is in the top 3% for ar per share. AR per Share has fluctuated over the past 10 years, ranging from $11.84 in FY2016 to $54.73 in FY2024.
Based on SEC 10-K filings.
50.49 in FY2025 with a 5-year CAGR of +13.3%. Ranks 3rd among 113 companies in Health Care.
Remained stable around $50.49 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +2.9%
- 5-Year CAGR
- +13.3%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 113This company $50.49 Sector average $28.83
▼
+75.1% above sector average
Key checks
Key Insights
- In FY2025, ar per share decreased 7.7% year-over-year.
- Ranks #3 out of 113 companies in the Health Care sector.
- Peak ar per share was recorded in FY2024.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.03 (safe zone, above 2.9 threshold)
- Strong profit margin: 32.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $50.49 | -7.7% |
| FY2024 | $54.73 | +8.4% |
| FY2023 | $50.51 | +9.1% |
| FY2022 | $46.30 | -12.1% |
| FY2021 | $52.67 | +94.3% |
| FY2020 | $27.10 | +49.6% |
| FY2019 | $18.12 | +22.3% |
| FY2018 | $14.82 | +11.0% |
| FY2017 | $13.35 | +12.7% |
| FY2016 | $11.84 | +14.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026